Company profile: Quirem
1.1 - Company Overview
Company description
- Provider of next-generation holmium-166-based radioactive microspheres for Selective Internal Radiation Therapy (SIRT), a radioembolization treatment for liver tumors, developing and commercializing SIRT microspheres and medical devices.
Products and services
- Holmium-166 SIRT Microspheres: Holmium-166-based radioactive microspheres engineered for treating liver tumors via radioembolization, enabling Selective Internal Radiation Therapy using holmium-166 as the therapeutic radioisotope
- Next-Generation SIRT Microsphere Development: Next-generation, SIRT-focused development architects holmium-based microspheres for liver tumors, creating products explicitly built on the radioisotope Holmium-166
- Commercialization of SIRT Microspheres and Medical Devices: SIRT-specific commercialization produces holmium-166 microsphere products and medical devices for treating liver tumors through radioembolization
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quirem
Lexington Medical
HQ: United States
Website
- Description: Provider of minimally invasive surgical stapling solutions, manufactured by a Boston-based medical device company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexington Medical company profile →
Meritage Pharma
HQ: United States
Website
- Description: Provider of prescription products for gastrointestinal and atopic diseases, offering budesonide-based therapies, including an oral budesonide suspension and budesonide API used in treatments for pediatric asthma, allergic rhinitis, and Crohn's disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meritage Pharma company profile →
Given Imaging
HQ: United States
Website
- Description: Provider of GI medical devices, offering the broadest portfolio of capsule solutions to visualize the gastrointestinal tract and, through its Sierra Scientific subsidiary, specialty GI diagnostic solutions and high-resolution manometry; pioneered capsule endoscopy, now the gold standard.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Given Imaging company profile →
Rodeo Therapeutics
HQ: United States
Website
- Description: Provider of small-molecule therapies targeting novel enzyme targets and biological pathways to promote tissue repair and regeneration, with an initial focus on treating inflammatory bowel disease and promoting blood cell reconstitution following bone marrow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rodeo Therapeutics company profile →
Alcresta Therapeutics
HQ: United States
Website
- Description: Provider of enzyme-based, point-of-care nutritional products for infants, aging adults, and patients with acute or chronic diseases. Offerings include RELiZORB, a digestive enzyme cartridge for enteral feeding to break down fats (for conditions like cystic fibrosis and pancreatitis); Next-Generation RELiZORB supporting continuous and bolus feeds; ALC-078 for short bowel syndrome; and ALC-079 for NICU use in premature infants.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alcresta Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quirem
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quirem
2.2 - Growth funds investing in similar companies to Quirem
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quirem
4.2 - Public trading comparable groups for Quirem
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →